| |
| |
| Exchange: |
New York Stock Exchange |
| Security
Type: |
Common |
| Shares
Out: |
1,340,000,000 |
| Market
Cap: |
106.85(B) |
| Last
Volume: |
23,255,346 |
Avg
Vol: |
0 |
| 52
Week Range: |
$69.43 - $91.38 |
|
| Level
I Sector: |
Health Care |
| Level
II Sector: |
Health Services |
| Level
III Sector: |
Medical Appliances & Equipment |
|
Member Indexes:
|
Rankings:
|
|
| Insider 3 Months : - |
| Insider 6 Months : - |
| Insider 3/6 Months : - |
|
| Guru Rank Number : 125 |
| Guru Rank Value : 7.5 |
| Guru Occurances : 3 |
|
|
|
|
|
| |
|
Company Profile Medtronic is a medical technology, services and solutions company. Co.'s four operating and reportable segments are as follows: Cardiovascular Portfolio, which is made up of the cardiac rhythm and heart failure, structural heart and aortic, and coronary and peripheral vascular divisions; Medical Surgical Portfolio, which is made up of the surgical innovations and respiratory, gastrointestinal, and renal divisions; Neuroscience Portfolio is made up of the cranial and spinal technologies, specialty therapies, and neuromodulation divisions; and Diabetes Operating Unit, which develops, manufactures, and markets products and services for the management of Type 1 and Type 2 diabetes.
|
|
|
D/I:
|
|
|
D
is for direct shares.
I is
for indirect shares.
D/I
refers to the Direct or Indirect
shares traded vs. held. |
|
|
|
Forms:
|
|
|
A
Form 4 is a form filed
by an insider to indicate a change
in ownership.
A Form
3 is a form filed by
an insider to indicate an
initial ownership of a security. |
|
|
|
3m +/-:
|
|
|
|
This
represents the company's 3 month
price change. The initial price
is based on the closing price
of the stock on the day the transaction
took place. Purchases & sales
are viewed as long & short
positions respectively.
|
|
|
|
Actions:
|
|
|
| B |
Buy |
| S |
Sell |
| OE |
Option
Exercised |
| A |
Acquired |
| D |
Disposed |
| AB |
Automatic
Buy |
| AS |
Automatic
Sell |
| IO |
Initial
Ownership |
|
|
|
|
Download:
|
|
|
Download only Transactions
Forms. (Default)
Download
only Summary Infomation.
Download
both Transactions and Summary Data
|
|
|
|
|
| |
| |
Summary (Direct Transactions Only)  |
3 Months |
6 Months |
12 Months |
24 Months |
| Total Shares Bought |
0 |
0 |
0 |
0 |
| Total Buy Value |
$0 |
$0 |
$0 |
$0 |
| Total People Bought |
0 |
0 |
0 |
0 |
| Total Buy Transactions |
0 |
0 |
0 |
0 |
| Total Shares Sold |
31,549 |
36,546 |
56,412 |
75,447 |
| Total Sell Value |
$2,684,057 |
$3,094,660 |
$4,783,517 |
$6,318,268 |
| Total People Sold |
2 |
3 |
5 |
5 |
| Total Sell Transactions |
2 |
3 |
8 |
10 |
| End Date |
2024-01-28 |
2023-10-27 |
2023-04-28 |
2022-04-28 |
|
| Filer's Name |
Relation Title |
Off-Dir-10% |
Tran. Date |
Form |
Action |
Price |
Mkt Value |
D/I |
Shares |
Holdings |
Rank
|
|
|
| 3m +/- |
|
|
Form |
  Ten Hoedt Rob |
EVP & President EMEA |
• • – |
2021-03-02 |
4 |
OE |
$34.88 |
$250,020 |
D/D |
7,168 |
50,965 |
|
- |
|
| Salmon Sean |
EVP & Group President Diabetes |
• • – |
2021-02-01 |
4 |
A |
$0.00 |
$0 |
D/D |
1,979 |
30,007 |
|
- |
|
| Surface Carol A |
SVP, Chief HR Officer |
• • – |
2020-12-28 |
4 |
S |
$114.90 |
$1,723,500 |
D/D |
(15,000) |
34,150 |
|
-10% |
|
| Lerman Bradley E |
SVP General Counsel & Corp Sec |
• • – |
2020-12-22 |
4 |
S |
$115.56 |
$301,034 |
D/D |
(2,605) |
51,543 |
|
-12% |
|
| White Robert John |
EVP & Pres. Medical Surgical |
• • – |
2020-12-18 |
4 |
S |
$115.46 |
$1,261,978 |
D/D |
(10,930) |
44,922 |
|
-12% |
|
| White Robert John |
EVP & Pres. Medical Surgical |
• • – |
2020-12-16 |
4 |
GA |
$0.00 |
$0 |
I/I |
1,500 |
1,500 |
|
- |
|
| White Robert John |
EVP & Pres. Medical Surgical |
• • – |
2020-12-16 |
4 |
GD |
$0.00 |
$0 |
D/D |
1,500 |
55,852 |
|
- |
|
| Parkhill Karen L |
EVP & Chief Financial Officer |
• • – |
2020-12-15 |
4 |
AS |
$114.33 |
$76,601 |
D/D |
(670) |
86,897 |
|
13% |
|
| Lerman Bradley E |
SVP General Counsel & Corp Sec |
• • – |
2020-11-09 |
4 |
AS |
$113.13 |
$2,343,488 |
D/D |
(20,715) |
54,148 |
|
3% |
|
| Lerman Bradley E |
SVP General Counsel & Corp Sec |
• • – |
2020-11-09 |
4 |
OE |
$62.76 |
$1,300,073 |
D/D |
20,715 |
74,863 |
|
- |
|
| Coyle Michael J |
EVP & Group Pres, Cardiac&Vasc |
• • – |
2020-11-03 |
4 |
D |
$103.13 |
$40,530 |
D/D |
(393) |
190,390 |
|
- |
|
| Kuntz Richard |
SVP & Chief Medical & Science |
• • – |
2020-11-03 |
4 |
D |
$103.13 |
$28,154 |
D/D |
(273) |
74,009 |
|
- |
|
| Wall Brett A. |
EVP & Group Pres Restora Thera |
• • – |
2020-11-03 |
4 |
D |
$103.13 |
$23,617 |
D/D |
(229) |
18,715 |
|
- |
|
| Lerman Bradley E |
SVP General Counsel & Corp Sec |
• • – |
2020-11-03 |
4 |
D |
$103.13 |
$34,755 |
D/D |
(337) |
54,148 |
|
- |
|
| Liddicoat John R |
EVP & President of Americas |
• • – |
2020-11-03 |
4 |
D |
$103.13 |
$13,201 |
D/D |
(128) |
41,989 |
|
- |
|
| Salmon Sean |
EVP & Group President Diabetes |
• • – |
2020-11-03 |
4 |
D |
$103.13 |
$22,689 |
D/D |
(220) |
27,900 |
|
- |
|
| White Robert John |
EVP & President MITG |
• • – |
2020-11-03 |
4 |
D |
$103.13 |
$30,836 |
D/D |
(299) |
57,352 |
|
- |
|
| Ishrak Omar |
Executive Chairman |
• • – |
2020-10-15 |
4 |
GA |
$0.00 |
$0 |
I/I |
8,650 |
8,650 |
|
- |
|
| Ishrak Omar |
Executive Chairman |
• • – |
2020-10-15 |
4 |
GD |
$0.00 |
$0 |
I/I |
8,650 |
9,532 |
|
- |
|
| Hogan Randall J |
Director |
• • – |
2020-10-14 |
4 |
GA |
$0.00 |
$0 |
I/I |
36,798 |
36,798 |
|
- |
|
| Hogan Randall J |
Director |
• • – |
2020-10-14 |
4 |
GD |
$0.00 |
$0 |
D/D |
36,798 |
1,747 |
|
- |
|
| Ishrak Omar |
Executive Chairman |
• • – |
2020-10-09 |
4 |
GA |
$0.00 |
$0 |
D/D |
5,900 |
566,932 |
|
- |
|
| Ishrak Omar |
Executive Chairman |
• • – |
2020-10-09 |
4 |
GD |
$0.00 |
$0 |
I/I |
5,900 |
0 |
|
- |
|
| Ishrak Omar |
Executive Chairman |
• • – |
2020-10-09 |
4 |
S |
$108.40 |
$82,709 |
D/D |
(763) |
561,032 |
|
-6% |
|
| Anderson Richard H |
Director |
• • – |
2020-10-08 |
4 |
B |
$108.52 |
$499,952 |
D/D |
4,607 |
101,673 |
2.39 |
5% |
|
680 Records found
|
|
Page 9 of 28 |
|
|
0.49 (0.62%) 
